Hematology/Oncology

Top Story

Children’s Research Institute at Children’s Mercy appoints chief scientific officer

Children’s Research Institute at Children’s Mercy appoints chief scientific officer
February 6, 2016

Tom Curran, PhD, FRS, has been hired as chief scientific officer and executive director of Children’s Research Institute at Children’s Mercy Kansas City.

The Children’s Research Institute at Children’s Mercy Kansas City, established last year, is designed to focus the hospital’s future research efforts in four key areas: pediatric genomic medicine, clinical pharmacology, health services and outcomes, and health care delivery.

Meeting News Coverage

Oncologists, PCPs disagree on who should provide cancer survivorship care

February 5, 2016
Oncologists and primary care physicians within the same integrated health system disagreed on who should ultimately manage care for survivors of cancer, according to…

ABIM continues to engage physicians on MOC updates

February 5, 2016
The ABIM has announced several new efforts aimed at including internists and subspecialists in the process of improving Maintenance of Certification assessments…
In the Journals

Artificial white light as effective as daylight photodynamic therapy for actinic keratosis

February 5, 2016
Artificial white light photodynamic therapy was as effective and tolerated as daylight photodynamic therapy in men with actinic keratosis, according to study results…
In the Journals

Panobinostat combinations extends PFS in heavily pretreated, relapsed multiple myeloma

February 5, 2016
Treatment with panobinostat, bortezomib and dexamethasone significantly improved PFS in patients with relapsed and refractory multiple myeloma previously treated with…
More News Headlines »
CME

NSCLC Treatment on Target: Examining New Evidence and Advances

This activity is supported by an educational grant from Genentech, Inc. and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Eighty five percent of lung cancers are non-small…
More »
Video

VIDEO: Genomic profiling, identification of mutations, leads to therapeutic developments

January 28, 2016
More »
Featured
CME

Optimizing the Management of Metastatic Melanoma: Clinical Insights for Selecting First-line Therapy

This activity is supported by an independent educational grant from Merck & Co., Inc.

The incidence of melanoma is continuing to increase worldwide. In recent years, the treatment landscape for this…
More »
Current Issues
View the Current Issue
HemOnc Today